Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10544467
Solid tumor methylation markers and uses thereof
granted patentUS 10543283
Intranasal administration of guanidinylated aminoglycosides
granted patentUS 10543280
Stabilization of biomolecules using sugar polymers
granted patentUS 10543221
Beta-lactamase inhibitors, formulations, and uses thereof
granted patentUS 10537535
Histone deacetylase inhibitors
granted patentUS 10537529
Cell-free methods of producing vault particles and vault particles resulting therefrom
granted patentUS 10537528
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine compounds
granted patentUS 10533190
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10533056
Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics
granted patentUS 10526619
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10526359
Thiosaccharide mucolytic agents
granted patentUS 10520499
Methods of diagnosing and treating autism
granted patentUS 10519467
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10518074
Compositions comprising nanostructures for cell, tissue and artificial organ growth, and m
granted patentUS 10517942
Polypeptide glycopeptide fragments from the V1/V2 and V3 domains of the HIV-1 envelope pro
granted patentUS 10517898
Compositions and methods related to hematologic recovery
granted patentUS 10517491
Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography
granted patentUS 10513712
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 10512669
Blockade of inflammatory proteases with cyclic peptides
granted patentUS 10512630
Compositions and methods for treating cancer
granted patentUS 10507284
Daily periodic target-zone modulation in the model predictive control problem for artifici
granted patentUS 10507239
V1/V2 fragments of a HIV-1 envelope glycoprotein
granted patentUS 10501816
Compositions and methods for detecting human pegivirus 2 (HPgV-2)
granted patentUS 10500271
Compositions and methods for self-adjuvanting vaccines against microbes and tumors
granted